| LCD | Title |
Effective Date |
| L39919 |
MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms -Palmetto GBA |
08/17/2025 |
| L39923 |
MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms -Noridian Healthcare Solutions, LLC |
08/17/2025 |
| L39927 |
MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms -Noridian Healthcare Solutions, LLC |
08/17/2025 |
| L39933 |
MolDX: Genetic Testing for Heritable Thoracic Aortic Disease -Palmetto GBA |
08/17/2025 |
| L39935 |
MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis-Palmetto GBA |
08/17/2025 |
| L39938 |
MolDX: Genetic Testing for Heritable Thoracic Aortic Disease -CGS Administrators, LLC |
08/17/2025 |
| L39940 |
MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis-CGS Administrators, LLC |
08/17/2025 |
| L39944 |
MolDX: Genetic Testing for Heritable Thoracic Aortic Disease -Noridian Healthcare Solutions, LLC |
08/17/2025 |
| L39946 |
MolDX: Genetic Testing for Heritable Thoracic Aortic Disease -Noridian Healthcare Solutions, LLC |
08/17/2025 |
| L39948 |
MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis-Noridian Healthcare Solutions, LLC |
08/17/2025 |
| L39950 |
MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis-Noridian Healthcare Solutions, LLC |
08/17/2025 |
| L39987 |
MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis-Wisconsin Physicians Service Insurance Corporation |
08/17/2025 |
| L39989 |
MolDX: Genetic Testing for Heritable Thoracic Aortic Disease-Wisconsin Physicians Service Insurance Corporation |
08/17/2025 |
| L40000 |
MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms -CGS Administrators, LLC |
08/17/2025 |
| L40022 |
MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms-Wisconsin Physicians Service Insurance Corporation |
08/17/2025 |
| L39756 |
Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers-CGS Administrators, LLC |
01/01/2026 |
| L39760 |
Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers-Noridian Healthcare Solutions, LLC |
01/01/2026 |
| L39764 |
Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers-Noridian Healthcare Solutions, LLC |
01/01/2026 |
| L39806 |
Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers-Palmetto GBA |
01/01/2026 |
| L39828 |
Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers-National Government Services, Inc. |
01/01/2026 |
| L39865 |
Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers-Wisconsin Physicians Service Insurance Corporation |
01/01/2026 |
